Theravance Biopharma
TBPH
#6486
Rank
โ‚น83.04 B
Marketcap
Country
โ‚น1,600
Share price
0.00%
Change (1 day)
0.03%
Change (1 year)

Revenue for Theravance Biopharma (TBPH)

Revenue in 2026 (TTM): โ‚น9.51 Billion

According to Theravance Biopharma 's latest financial reports the company's current revenue (TTM ) is โ‚น9.79 Billion. In 2025 the company made a revenue of โ‚น9.64 Billion an increase over the revenue in the year 2024 that were of โ‚น5.52 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Theravance Biopharma from 2013 to 2026

Annual revenue

Year Revenue Change
2026 (TTM) โ‚น9.51 B-1.34%
2025 โ‚น9.64 B74.67%
2024 โ‚น5.52 B15.53%
2023 โ‚น4.78 B12.51%
2022 โ‚น4.24 B3.21%
2021 โ‚น4.11 B-21.66%
2020 โ‚น5.25 B0.38%
2019 โ‚น5.23 B24.02%
2018 โ‚น4.22 B329.68%
2017 โ‚น0.98 B-70.28%
2016 โ‚น3.30 B18.09%
2015 โ‚น2.79 B277.92%
2014 โ‚น0.74 B5205.45%
2013 โ‚น13.96 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Corcept Therapeutics
CORT
โ‚น90.50 B 823.82%๐Ÿ‡บ๐Ÿ‡ธ USA
Collegium Pharmaceutical
COLL
โ‚น76.56 B 681.50%๐Ÿ‡บ๐Ÿ‡ธ USA
Catalyst Pharmaceuticals
CPRX
โ‚น56.06 B 472.29%๐Ÿ‡บ๐Ÿ‡ธ USA
Catalent
CTLT
โ‚น415.32 B 4,139.25%๐Ÿ‡บ๐Ÿ‡ธ USA